Floatz logo

Keppra

Epilepsy, Partial

Mario Negri Institute for Pharmacological ResearchPhase 4 / ApprovedDormant
A
80/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Epilepsy, Partial cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
Dhaka Medical College
Phase 4BBB
Seletracetam
UCB Pharma
Phase 2/3BB
HUMAN IMMUNOGLOBULINS
Emory University
Phase 2CCC
Retigabine
GlaxoSmithKline
Phase 1CC

Same molecule, other indications

Keppra is also rated in:

Epilepsy, Tonic-clonicDormant
BBB
Indicative ·
78 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →
epilepsy with generalized tonic-clonic seizuresDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →